MedPath
FDA Approval

Diphenoxylate Hydrochloride and Atropine Sulfate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Lohxa
DUNS: 079872715
Effective Date
September 10, 2019
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Atropine(0.025 mg in 5 mL)
Diphenoxylate(2.5 mg in 5 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Lohxa

Lohxa

079872715

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Diphenoxylate Hydrochloride and Atropine Sulfate

Product Details

NDC Product Code
70166-630
Application Number
ANDA087708
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
September 10, 2019
ALCOHOLInactive
Code: 3K9958V90MClass: IACTQuantity: 0.75 mL in 5 mL
FD&C RED NO. 40Inactive
Code: WZB9127XOAClass: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSLClass: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8Class: IACT
GLYCERINInactive
Code: PDC6A3C0OXClass: IACT
MALTOLInactive
Code: 3A9RD92BS4Class: IACT
POTASSIUM SORBATEInactive
Code: 1VPU26JZZ4Class: IACT
SORBITOLInactive
Code: 506T60A25RClass: IACT
AtropineActive
Code: 03J5ZE7KA5Class: ACTIBQuantity: 0.025 mg in 5 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
Code: W24OD7YW48Class: ACTIBQuantity: 2.5 mg in 5 mL
© Copyright 2025. All Rights Reserved by MedPath